Immunic is trading 5.1% up at $13.71 as U.S. equities rebound following upbeat tech earnings and favorable economic data.
- The broader market is seeing significant gains, with the Nasdaq Composite rising 2.56% and the S&P 500 up 1.24% following strong Microsoft results.
- Investor sentiment improved after cooling PCE inflation data, which has bolstered risk appetite across the technology and healthcare sectors.
- There are no company-specific catalysts, earnings, or clinical updates for Immunic today, suggesting the move is driven primarily by macro-level market trends.